Tarek Rabah

Throughout his career, Tarek Rabah has brought together high-functioning teams that challenge conventional thinking and deliver results in complex business environments. His commitment to empowering and supporting those around him has unlocked innovation and directly impacted the lives of patients. As a citizen of the world, Tarek brings an intuitive global perspective that infuses diversity, transparency, and performance accountability as key tenets in his business philosophy.

Tarek is a growth-oriented executive with extensive experience leading large, multifaceted commercial organizations. In his more than 20 years of experience, he has successfully launched brands and led divisions with AstraZeneca and Novartis in the United States, Europe, South America, Japan, and the Middle East. His expertise spans therapeutic areas in highly competitive and complex healthcare categories. For Tarek, leadership is not about having all the answers, rather it is about creating an environment where Otsuka-people are deeply connected to their purpose and the people they serve.

Tarek joined Otsuka in 2022 as President & CEO of Otsuka’s North America Pharmaceutical Business, with responsibility in the US and Canada. Driven by his personal passion to improve the lives of people, Tarek is leading Otsuka’s efforts to introduce products, programs, policies, and advocacy initiatives that help address unmet medical needs and untapped market opportunities.

He holds a BS in Biology and a BA in Business from the American University of Beirut, and an MBA from McGill University. He is fluent in five languages.